Pain Medicine, Interventional Pain Medicine · Memphis, TN
NPI
1043387624
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
55 Humphreys Center Drive Suite 200, Pain Clinic Associates PC
Memphis, TN, 38120
Phone (901) 747-0040
Groups this clinician bills Medicare through
Medicare paid, 2024
$563K
14,648 services
Medicare patients, 2024
1,130
Average age 73
Drug cost, 2024
$135K
2,141 prescriptions
Company payments, 2025
$259
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Moacir Schnapp was code 99214 (office e&m - established), 3,543 times for 987 patients. In total Moacir Schnapp billed 14,648 services in 52 codes, and Medicare paid $563K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 3,543 | 987 | $85.69 | $304K |
| 97110 PT Treatment | Office | 2,532 | 162 | $16.40 | $42K |
| 97530 PT Treatment | Office | 1,524 | 162 | $22.70 | $35K |
| 80307 Drug Tests | Office | 409 | 381 | $60.19 | $25K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 381 | 12 | $0.10 | $37.86 |
| 97140 PT Treatment | Office | 300 | 71 | $14.86 | $4,458 |
| 99213 Office E&M - Established | Office | 283 | 213 | $61.61 | $17K |
| 99204 Office E&M - New | Office | 228 | 228 | $115.56 | $26K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 211 | 82 | $0.08 | $17.83 |
| 64493 Nerve Block Injection - Back | Facility | 139 | 87 | $92.46 | $13K |
| 64494 Nerve Block Injection - Back | Facility | 129 | 82 | $52.76 | $6,806 |
| 97162 PT/OT Evaluation | Office | 98 | 88 | $69.58 | $6,818 |
| G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 95 | 27 | $6.38 | $606 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 92 | 20 | $0.59 | $54.64 |
| 62323 Nerve Block Injection - Back | Facility | 92 | 80 | $69.17 | $6,364 |
By year: 2022 $681K for 14,237 services; 2023 $666K for 17,422 services; 2024 $563K for 14,648 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 409 | 381 | $60.19 | $25K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 53 | 49 | $153.46 | $8,133 |
Medicare prescription drug claims, 2024
In 2024, the drug Moacir Schnapp prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 474 prescriptions and refills. In total Moacir Schnapp wrote 2,141 Medicare prescriptions that cost $135K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 474 | 474 | 218 | $7,607 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 257 | 257 | 127 | $5,265 |
| Gabapentin Generic | 225 | 255 | 119 | $2,306 |
| Tramadol Hcl Generic | 103 | 103 | 62 | $614 |
| Fentanyl Generic | 99 | 99 | 30 | $13K |
| Clonazepam Generic | 98 | 98 | 41 | $389 |
| Buprenorphine Generic | 84 | 84 | 32 | $15K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 73 | 79 | 37 | $387 |
| Morphine Sulfate Er Morphine Sulfate | 71 | 71 | 31 | $1,655 |
| Pregabalin Generic | 59 | 65 | 33 | $1,206 |
| Dronabinol Generic | 59 | 60 | 32 | $7,982 |
| Lorazepam Generic | 54 | 54 | 35 | $311 |
| Hydromorphone Hcl Generic | 45 | 45 | 12 | $655 |
| Xtampza Er Oxycodone Myristate | 38 | 38 | 13 | $13K |
| Topiramate Generic | 26 | 30 | Under 11 | $88.41 |
Brand drugs: 167 claims; generic drugs: 1,974 claims; opioid claims: 1,233.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Moacir Schnapp $259 ($259 in general payments such as food, travel and fees) from 9 companies. The largest payer was Pfizer Inc. with $58.67.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 3 | $58.67 |
| Abbott Laboratories ABT | 2 | $33.99 |
| Axsome Therapeutics, Inc. AXSM | 1 | $31.52 |
| Abbvie Inc. ABBV | 1 | $30.42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $24.59 |
| Protega Pharmaceutials Inc | 1 | $23.27 |
| Averitas Pharma Inc. | 1 | $21.55 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $20.4 |
| Boston Scientific Corporation BSX | 1 | $14.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.